Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Hahn Urges Fixed Terms For US FDA Leaders
Mar 29 2021
•
By
Derrick Gingery
Stephen Hahn said in the interview that decisions on hydroxychloroquine were correct at the time they were made. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Agency Leadership
More from Pink Sheet